Abstract
INTRODUCTION 43
Organometallic compounds, especially platinum complexes, are widely applied as anti-cancer 44 chemotherapeutics (1). However, due to their drawbacks (i.e. severe side effects, insurgence 45 of tumor resistance, etc.), a variety of complexes of other transition metals such as copper, 46 gold or ruthenium have been investigated as potential alternative anti-cancer drug candidates 47 (2-10). Among the different metal complexes studied, arene ruthenium complexes showed 48 very promising anti-cancer properties with 50% inhibitory concentration (IC 50 ) values in the 49 low micromolar range, and certain selectivity for tumor cells over non-tumorigenic cells (11-50 13) . One such compound, namely RAPTA-C, is currently in pre-clinical evaluation (14) . 51
Recently, some of us have shown that thiolato-bridged dinuclear arene ruthenium complexes, 52
in particular trithiolato dinuclear complexes of the type [ and S. epidermidis with minimum inhibitory concentrations (MICs) of 0.625 μM. Moreover,beta-gal (transgenic T. gondii RH expressing the beta-galactosidase gene from E. coli (50)) 119 were maintained in Vero cells, and were isolated and separated from their host cells as 120 described (24) . 121
In vitro assessment of drug efficacy. To study the effects of compounds against T. gondii 122 tachyzoites in vitro, 0.5 mM stock solutions of complexes were prepared in water, sterile 123 filtered, and stored at 4 °C. 124
For assessment of drug efficacy against T. gondii tachyzoites, parasites were isolated (24) and 125 assays were performed using HFF as host cells (24) . In short, 5 x 10 3 HFF cells / well) were 126 grown to confluence in a 96 well plate in phenol-red free culture medium at 37 °C with 5% 127 CO 2 . Cultures were infected with freshly isolated T. gondii beta-gal tachyzoites beta-gal 128 tachyzoites (1 x 10 3 / well) and drugs were added at the time point of infection. Initial 129 assessments of drug efficacy were done by exposing parasite cultures to 2500 nM, 250 nM, 130 25 nM or 2.5 nM of each compound for a period of three days, or water was added as a 131 control. For IC 50 determinations, 6 selected complexes (1-5, and 9) were added at 132 concentrations ranging between 0 and 2000 nM. After three days at 37 °C/ 5% CO 2 , plates 133 were centrifuged at 500 g, medium was removed, and cell cultures were lysed in PBS 134 containing 0.05% Triton-X-100. After addition of 10 µL of 5 mM chlorophenol red-β-D-135 galactopyranoside (CPRG; Roche Diagnostics, Rotkreuz, Switzerland) dissolved in PBS, the 136 absorption shift was measured at 570 nm wavelength at various time points on a VersaMax 137 multiplate reader (Bucher Biotec, Basel, Switzerland). The activity, measured as the release of 138 chlorophenol red over time, was proportional to the number of live parasites down to 50 per 139 well as determined in pilot assays. IC 50 values were calculated after the logit-log-140 transformation of relative growth and subsequent regression analysis by the corresponding 141 software tool contained in the Excel software package (Microsoft, Seattle, WA) . 142
In one time course experiment, 9 (100 nM) was added to HFF monolayers either 10 min prior 143 to infection or 1 h, 5 h or 24 h post-infection with T. gondii tachyzoites. The proliferation of 144 tachyzoites was measured after 2 days of culture as described above. 145
For long term treatment assays, T. gondii infected HFF grown in T25 culture flasks were 146 exposed to 250 nM of 1, 2 or 9 for a period of 15 days, after which the cultures were washed 147 with medium and were further maintained in medium devoid of drugs. Regrowth of parasites 148 was monitored on a daily basis by light microscopy 149
Cytotoxicity assays on non-infected confluent HFF were performed also in 96 well plates by 150 exposing HFF to a concentration range of 2.5 nM, 25 nM, 250 nM and 2.5 µM of each 151 compound, and assessment of the viability by AlamarBlue assay as described (51). 152
Transmission electron microscopy (TEM). HFF (5 x 10
4 per inoculum) cultured in T25 153 tissue culture flasks for 24 h were infected with 10 5 T. gondii beta-gal tachyzoites, and 200 154 nM of 1, 2 or 9 were added at 24 h post-infection. After 6, 24 or 48 h, cells were harvested 155 using a cell scraper, and they were placed into the primary fixation solution (2.5 % 156 glutaraldehyde in 100 mM sodium cacodylate buffer pH 7.3) for 2 h. Specimens were then 157 washed 2 times in cacodylate buffer and were post-fixed in 2% OsO4 in cacodylate buffer for 158 2 h, followed by washing in water, pre-staining in saturated uranyle acetate solution, and step 159 wise dehydration in ethanol. They were then embedded in Epon 812-resin, and processed for 160 TEM as described (24). Specimens were viewed on a Phillips 400 transmission electron 161 microscope operating at 80 kV. 162
Coupling of compound 9 to epoxy-activated sepharose, affinity chromatography and 163 identification of a drug-binding protein by liquid chromatography tandem mass 164 spectrometry (LC-MS/MS) analysis. To prepare a complex-9-sepharose matrix, 20 mg of 165 complex 9 were added to 0.5 mg of epoxy-sepharose suspended in 2 mL of coupling buffer 166 (NaCO 3 0.1 M, pH 9.5) followed by an incubation for two days at 37 °C on a shaker. 167
Furthermore, a mock epoxy-sepharose column was prepared by treatment with coupling 168 buffer without complex 9 and blocking with ethanolamine. Prior to the runs, both columns 169 were combined in a tandem (mock column first, then complex-9-column) and washed with 25 170 mL of PBS equilibrated at 20 °C. 171
To identify potential binding proteins both from T. gondii and from the host cell, three T75-172 flasks containing HFF monolayers were infected with 2 x 10 7 T. gondii tachyzoites and 173 incubated for 3-4 days. Then, cells were harvested by scraping and pelleted (1,000 g, 10 min, 174 4•C). For protein extraction, frozen pellets were resuspended in 1 ml ice cold PBS containing 175 1% Triton-X-100 and 1 mM phenyl-methyl-sulfonyl-fluoride. Suspensions were vortexed 176 thoroughly, and centrifuged (15,200 x g), 10 min, 4•C). Extraction of pellets was repeated 177 twice. Supernatants were combined (5-10 mg of total protein) and subjected to affinity 178 chromatography by loading onto the column tandem at a flow rate of 0.25 mL/min. The 179 columns were washed with PBS until a flat baseline was detected (ca. 20 mL PBS). The 180 columns were separated, and proteins binding to the columns were eluted with a pH shift 181 (glycine Cl − 100 mM, pH 2.9). Fractions (3 mL) were taken before, during and after elution 182 and precipitated overnight with 80% acetone at -20 °C. The precipitates were solubilized in 183 30 µL of Laemmli buffer and were separated by 10% sodium dodecyl sulphate 184 polyacrylamide gelelectrophoresis (SDS-PAGE) using a Hoefer Minigel 250 Apparatus (GE 185 Healthcare, Little Chalfont, UK). Proteins were visualized by silver staining. 186
For mass spectrometry analysis, colloidal Coomassie staining was applied and selected 187 protein bands were cut out with a clean scalpel, placed into Eppendorf tubes containing 188 ethanol/distilled water (1:4) and were stored at 4 °C. In-gel digestion/liquid chromatography respectively (see Table 1 ). Accordingly, host cell toxicity was investigated for these three 207 complexes. In the presence of 1, HFF vitality was decreased to 63% of the control value at a 208 concentration of 250µM, which was the highest concentration used in these assays. Thus, an 209 extrapolated, but purely theoretical, IC 50 value of 800 µM was calculated for 1, since the 210 solubility limit in water-based solutions is around 500 µM. 2 did not affect vitality of HFF up 211 to a concentration of 250 µM. 9, exhibiting the by far lowest IC 50 values, had an IC 50 for HFF 212 of approximately 5 µM. Thus, all three complexes affected T. gondii tachyzoites at low 213 nanomolar concentrations, and these effects were parasite-specific, with a high selective 214 toxicity index: > 23,000 for 1, > 16,000 for 2, and > 5,000 for 9. Interestingly, a long-term 215 for all three compounds. This indicates that these compounds acted in a parasitostatic rather 218 than parasiticidal manner. 219
Ultrastructural changes induced by Ru(II) complexes show that one of the primary 220 target organelles in T. gondii tachyzoites is the mitochondrion. To obtain more detailed 221 information on the subcellular effects of these 3 thiolato-bridged dinuclear arene ruthenium 222 complexes, TEM was performed on drug-treated HFF infected with T. gondii (Fig. 2, 3 ). Non-223 treated parasites, exemplified in Fig. 2 were located intracellularly and were undergoing 224 proliferation by endodyogeny within a parasitophorous vacuole (PV), surrounded by a distinct 225 PV membrane. These parasites exhibit the typical apicomplexan structural features, including 226 rhoptries, dense granules, micronemes, and a conoid at the anterior part. The parasite 227 mitochondrium, filled with a structured electron dense matrix, could be readily identified in 228 these non-treated parasites (Fig. 2C) . In cultures exposed to 1, alterations within the 229 mitochondria of T. gondii were evident already after 6 h of treatment, showing a progressive 230 degeneration of the electron-dense intra-mitochondrial matrix (Fig. 3B-C) . The interior 231 ultrastructural organization of these mitochondria was largely distorted and only membranous 232 residues were present in some cases. However, the outer membrane of the mitochondria was 233 still intact, and parasites maintained their overall shape. After 48 h of treatment with 1, T. 234 gondii tachyzoites had lost their characteristic shape, and parasites displayed a largely 235 distorted morphology, no internal organelles were recognizable anymore, and the PV and its 236 membrane were essentially lost. However, host cell mitochondria exhibited a normal 237 morphology with clearly discernable cristae (Fig. 3D) . Similar results were obtained in T. 238 gondii infected cultures treated with 2 (data not shown). For treatments with 9, mitochondrial 239 changes were not noted in T. gondii tachzyoites already after 6 h of treatment (data not 240 shown), but similar alterations as observed during treatments with 1 became evident after 24-241 induced largely similar ultrastructural changes by inducing distinct alterations in the 244 mitochondria, and could thus act with (a) similar or identical mechanism(s) of action. 245
Complex 9 affects extracellular parasites and interferes in adhesion, invasion or 246 intracellular establishment, but does not act efficiently against T. gondii proliferation 247 once parasites reside inside the host cell. Since long-term treatment studies as well as TEM 248 suggested that these ruthenium complexes did not act parasiticidal, we wanted to determine 249 whether these compounds affected host cell invasion, intracellular proliferation, or both. For 250 this, HFF monolayers were infected with T. gondii tachyzoites, and 9 (100 µM) was added 251 either concomitantly with the infection, or after 1 h, 5 h or 24 h post infection (Fig. 4) . 9 252 efficiently inhibited tachyzoite proliferation when added at the time point of infection and 253 also when applied at 5 h post-infection, but only partially when added 24 h post-infection. 254
Thus 9 acted mainly during first steps of the infection process (e.g. host cell invasion and 255 intracellular establishment), and only with limited efficacy once parasites resided inside the 256 host cell. 257
Complex 9 interacts with ribosomal proteins from T. gondii and from the host cell. By 258 affinity chromatography on complex-9-epoxy-sepharose, two major bands of approximately 259 50 kDa and 20 kDa were identified that were not present in the eluate of the mock column 260 (Fig. 5 A) . Mass spectrometry analysis identified ribosomal proteins of host and parasite 261 origin as major components of the 20-kDa-band (Table 1 ). The composition of the 50 kDa 262 band was more heterogeneous. As quantified both via protein match score summation and via 263 protein score -the major component of the 50 kDa-band was T. gondii elongation factor 1-264 alpha (TgEF1-alpha; Table 1 ) with a unique peptide coverage of nearly 50% of the sequence 265 (Fig. 5B) . The second most abundant protein was its human homologue. Moreover, other 266 proteins of human origin were identified in this fraction (Table 1) . 267
DISCUSSION 269
We here report on a series of 18 dinuclear thiophenolato-bridged arene ruthenium complexes, 270 which exhibit highly promising in vitro activities against T. gondii tachyzoites. The 271 organometallic complexes studied in this work have been previously described (15, 17, 47, 272 48). Very importantly, recent studies by some of us have shown that these dinuclear arene 273 ruthenium complexes are inert to ligand substitutions and remain stable for long period in 274 water solutions or in organic solvents like DMSO (16, 21) . These ruthenium complexes had 275 been originally generated for the treatment of cancer cells. Cancer cells and protozoan 276 parasites, including Toxoplasma, share several features: they both live and multiply in a host 277 organism and do not immediately kill their hosts, they have a potentially infinite proliferative 278 capacity, and escape in immune-compromised tissues. Cancer cells are largely resistant to 279 apoptosis, while Toxoplasma and Neospora are known to interfere in the programmed cell 280 death machinery of their host cell (52). Thus, we hypothesize that a potentially lucrative 281 starting point for the discovery of novel drug candidates against T. gondii and other 282 protozoans is to examine compounds that are being developed against cancer. 283
Among the 18 compounds studied, the trithiolato complexes 1, 2 and 9 were highly 284 efficacious against both parasites with IC 50 s ranging between 1.2 and 62 nM. In addition, 285 these compounds exhibited a highly favorable selective toxicity index of up to 23'000. TEM 286 demonstrated that one of the first organelles that exhibited ultrastructural alterations upon 287 treatment with these compounds was the tachyzoite mitochondrion, which lost its interior 288 membranous matrix and cristae already after 6-24 h. More severe distortion, including a 289 complete breakdown of other organelles within the parasite cytoplasm and a general 290 disintegration of the tachzoites and the parasitophorous vacuole and its membrane, was 291 observed after 48 h. 292
In comparison to other drugs, the in vitro results on complexes 1, 2 and 9 are encouraging. and 41 nM (24) however, with selective toxicity indeces below 100. As can be noticed from 300 the calculated Log P values (Table 1 ) and as previously observed against cancer cells (17), the 301 efficacy of inhibition is, to some extent, correlated to the lipophilicity of the complexes. 302
Unlike against A2780 and A2780cisR cancer cells, the most lipophilic complex, 2, is not the 303 most potent one against T. gondii, possibly suggesting that the different chemical nature of the 304 cell and T. gondii outer membranes could influence the uptake of dinuclear thiolato-bridged 305 arene ruthenium complexes. 306 While 1, 2 and 9 were highly efficacious against T. gondii and exhibited an excellent selective 307 toxicity, we obtained evidence that these compounds did not act in a parasiticidal manner. 308
Removal of the drugs after continuous treatments at 250 nM lasting up to 15 days did not 309 result in complete elimination of viable tachyzoites, and re-growth of parasites was observed 310 within 5-10 days after releasing the drug pressure. This was confirmed by TEM, where a 311 small number of largely intact tachyzoites were still found after 48 h of continuous in vitro 312 treatment. Similar results were previously reported for dicationic arylimidamides (54) and 313 ruthenium phosphite complexes in T. gondii (24), and for buparvaquone, the BKI-1294 as 314 well as for artemisinin derivatives in the closely related N. caninum (55) (56) (57) . In some of these 315 reports, rapid adaptation of T. gondii and N. caninum tachyzoites to increased concentrations 316 of drugs within a few days was documented (54, 56) . This outstanding adaptive ability 317 represents a major obstacle for the development of efficacious drugs against these parasites. 318
Nevertheless, the lack of parasiticidal activity in vitro still allows for excellent in vivo 319 caninum (55, 57) . 321
All three compounds had a profound impact on the ultrastructure of the parasite mitochondria, 322 which lost their characteristic electron dense matrix and cristae upon 6-24 h after initiation of 323 drug treatments. After 48 h, this impacted on the entire tachyzoites, leading in most cases to 324 severe alterations and death. Of note, mitochondria are also targeted by other drugs currently 325 used against apicomplexans, such as atovaquone, buparvaquone and decoquinate, which have 326 been shown to impair cytochrome b/c1 complex in Toxoplasma, Plasmodium and Theileria 327
parasites (58-61). 328
The mitochondrion represents an attractive drug target. The disruption of mitochondria has 329 been recently investigated as a potential novel chemotherapeutic mechanism for cancer 330 treatment, because it circumvents upstream apoptotic pathways that may be mutated or 331 
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How exactly the mitochondrion is targeted by our ruthenium complexes is not known. 345
Affinity chromatography using extracts from T. gondii-infected HFF lead to the identification 346 of TgEF1-alpha as well as its human homologue as major complex-3-binding partners. This is 347 not surprising since EF1-alpha is expressed in all eukaryotic cells and is highly conserved 348 
alterations. 356
In another apicomplexan parasite, Cryptosporidium parvum, CpEF1-alpha was shown to 357 localize to the apical region of C. parvum sporozoites, and antibodies directed against 358 CpTEF1-apha inhibited host cell invasion (75). The same was shown for T. gondii (76) Our 359 study also showed that complex 9 had a profound efficacy when applied at the early stages of 360 host cell infection, namely either during, or 1-5 h after, exposure of T. gondii tachyzoites to 361 host cells, but more limited efficacy was noted when added 24 h after infection. This would 362 be consistent with a mode of action that is relevant for invasion or early host cell 363 establishment. In addition, vaccination of mice with recombinant TgEF1-1alpha and a DNA 364 vaccine coding for TgEF1-alpha lead to significantly prolonged survival times in T. gondii 365 infected mice (76, 77) underlining the importance of TgEF1-alpha for the infection process. 366
As outlined in Table 1 , other ribosomal proteins both of host and parasite origin, and various 367 other host proteins, were found to bind to 9 as well. This may explain the low, but still 368 detectable, host cell toxicity of 9. 369 on August 9, 2017 by Universitaetsbibliothek Bern http://aac.asm.org/
In conclusion, we have identified three promising dinuclear thiolato-bridged arene ruthenium 370 complexes with promising and highly specific anti-parasitic activity, as assessed against T. 371 gondii. These complexes induce severe mitochondrial alterations within 6-24 h of drug 372 treatment, efficiently inhibit proliferation, but do not act in a parasiticical manner. One of 373 these complexes, compound 9, interacts with TgTEF1-alpha and other parasite and host 374 ribosomal proteins. Further studies will focus on the interactions of 9 and other promising 375 ruthenium complexes with putative apicomplexan drug targets, and on the use of these drugs 376 in vivo. 377
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